... The stock was almost 4% above a 99.80 buy point in a short IPO base. (NASDAQ: REGN ) sagged 4% lower. The Tarrytown, N.Y., biotech turned in earnings and revenue shy of analyst projections. The gap-down loss left shares 7% below last week's high. ...
http://ift.tt/1x0oVWH
http://ift.tt/1x0oVWH
No comments:
Post a Comment